Supplementary Announcement on Providing Guarantee for Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Supplementary Announcement on Providing Guarantee for Wholly-owned Subsidiary
Filed with SSE · · 1 page · Chinese
Release
Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Hainan Huluwa Pharmaceutical
- Announcement on Retirement of Director and Senior Management Member
- Announcement on Cefotaxime Sodium for Injection Passing the Generic Drug Consistency Evaluation
- Semi-annual Earnings Preannouncement for 2025
- Announcement on Obtaining Drug Registration Certificate for Cefprozil Oral Suspension
- Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report
Later from Hainan Huluwa Pharmaceutical
- Announcement on the Release of Pledged Shares by Shareholder
- Announcement on By-election of Director
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 6th Meeting of the 3rd Board of Directors
- Announcement on Obtaining Drug Registration Certificate for Cefdinir Capsules
Follow Hainan Huluwa Pharmaceutical into a list and get an email when it puts out news.
Follow Hainan Huluwa Pharmaceutical